BioIVT’s Trevor Smith, MS, MBA, product manager, immune cells, describes necessary considerations when preparing to manufacture a cell or gene therapy, from starting materials to safety endpoints.
Katie Farley, director, product management at MasterControl, explores five pharmaceutical trends, what’s driving them, and how adopting them can lead to eliminating manufacturing errors, enhancing performance, and gaining a competitive advantage.
Abbie Fisher, associate at European Intellectual Property Firm, Withers & Rogers, discusses patenting a new frontier in personalised medicine with AI-powered biomarker discovery.
Emmanuel Abate, president Genomic Medicine and head of Sustainability, Cytiva, reflects on the developments of the biotech industry in 2022 and despite the manufacturing challenges that remain, the focus on sustainable solutions must not be ignored.
In this editor's desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what's still to be done.
BD and Biocorp joined forces to improve the outcomes and adherence of self-administered drugs through connected drug delivery, by combining the use of digital technology with prefillable syringes.
In this case study, Zambon worked extensively to redefine the product profile due to the introduction of new raw material suppliers, with the concurrent aim to achieve an improvement of PSD with minimisation of fines and big agglomerates.
Adnan Khan, manager of pharma industries at Beckhoff UK, discusses the challenges of pharmaceutical production lines and how next-generation motion can help.
Mark Hilhorst, CEO of Jekson Vision, provides insight into the stringent quality checks needed that are crucial to improve patient safety in the pharma market, and how automation solutions can help with this, while meeting growing market demand.
Martino Picardo, chairman of Discovery Park and a director of Discovery Park Ventures, explores the funding barriers preventing the growth of female-led life sciences companies.
Dr. Nveed Chaudhary, chief scientific and regulatory officer at Broughton, shares how developments in inhaled drug delivery technology could both improve the treatment of diseases, and enable the delivery of a wider range of active substances.
Lonza's Giovanna Libralon, Small Molecules, and Iwan Bertholjotti, Bioconjugates, share insights on payload-linker manufacturing and the global market trends for ADC-based therapies, along with the antibodies that help increase the precision of ADCs.
